Featured Story Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL February 15, 2023-Sera Prognostics
Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study February 3, 2023-Conformal
Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models August 1, 2022-Instylla Inc.
PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting Stent May 31, 2022-PanTher Therapeutics
Sera Prognostics Presents Data Demonstrating the Health & Economic Benefit of PRETRM® Testing at Ispor Annual Meeting May 20, 2022-Sera Prognostics
Sera Prognostics and Newborn Foundation Partner to Reduce Risks Associated with Preterm Birth and Improve Health Equity Through the “Every Mother, Every Baby” Project May 5, 2022-Sera Prognostics
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting March 18, 2022-Sera Prognostics
Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest March 16, 2022-Avive
